$4.27
0[0.00%]
At close: May 8
$4.27
0[0.00%]
PreMarket: 4:20PM EDT
Revance Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Revance Therapeutics using advanced sorting and filters.
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
---|
Revance Therapeutics (RVNC) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $0.00, which beat the estimate of $-0.75.
The Actual Revenue was $0K, which missed the estimate of $56.6M.
Browse earnings estimates, EPS, and revenue on all stocks.